Losartan
Hypertension, Reduction of the risk of stroke in patients with hypertension and left ventricular..., Treatment of diabetic nephropathy
Boxed warning
- WARNING: FETAL TOXICITY When pregnancy is detected, discontinue losartan potassium as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus [see Warnings and Precautions (5.1) ]. WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue losartan potassium as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing ... (see full label)
Indications
- Hypertension
- Reduction of the risk of stroke in patients with hypertension and left ventricular...
- Treatment of diabetic nephropathy
Adult dosing
- hypertension: dose: 50; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: Usual adult dose: 50 mg once daily.
- diabetic nephropathy: dose: 50; unit: mg; route: PO; interval: once daily; increase to 100 mg once daily for BP; fixed: true; labelExcerpt: Nephropathy in Type 2 Diabetic Patients • Usual dose: 50 mg once daily.
Pediatric dosing
- hypertension: dose: 0.7; unit: mg/kg; route: PO; interval: once daily (starting dose); weightBased: true; maxDose: 50; maxDoseAbsolute: true; labelExcerpt: Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg).
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Recommended starting dose 25 mg once daily for mild-to-moderate impairment.
Contraindications
- Hypersensitivity
- Coadministration with aliskiren in patients with diabetes
Clinical pearls
- Monitor renal function and serum potassium periodically.
- Correct volume or salt depletion prior to initiation to prevent symptomatic hypotension.
- Not recommended in children <6 years or those with GFR <30 mL/min/1.73 m2.
Source and review
- DailyMed label (losartan potassium), Set ID 021cd76a-b093-4704-8410-5e7d01e20a54, effective 2026-08-27. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties